Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cell Death and Differentiation|November 13, 2010
Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signalingA-S Gabet, S Coulon, A Fricot, et al.
Leukemia|July 4, 2012
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALLL Lhermitte, R Ben Abdelali, P Villarèse, et al.
Leukemia|June 9, 2017
TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcomeP Villarese, C Lours, A Trinquand, et al.
European Journal of Haematology|October 12, 2024
Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis InvolvementR Liévin, B Burroni, E Balducci, et al.
Cytometry. Part B, Clinical Cytometry|October 2, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyC Fossat, M Roussel, I Arnoux, et al.
Blood Cancer Journal|December 10, 2016
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL studyA Desjonquères, P Chevallier, X Thomas, et al.
Leukemia|September 6, 2012
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsT Kalina, J Flores-Montero, V H J van der Velden, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Leukemia|May 4, 2012
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesJ J M van Dongen, L Lhermitte, S Böttcher, et al.
Leukemia|September 13, 2003
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)R Berger, N Dastugue, M Busson, et al.
Pageof 3